Silvia Cammarone

Dr. Silvia Cammarone

Department of Chemistry and Technology of Drugs, Sapienza University of Rome
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
FCFloriana Cappiello
Floriana Cappiello
MLMaria Rosa Loffredo
Maria Rosa Loffredo
CPcristina del plato
cristina del plato
Silvia CammaroneSilvia Cammarone
Silvia Cammarone
Bruno CasciaroBruno Casciaro
Bruno Casciaro
Francesca GhirgaFrancesca Ghirga
Francesca Ghirga
The discovery of antibiotics has revolutionized the medicine and treatment of microbial infections. However, the current scenario has highlighted the difficulties in marketing new antibiotics and an exponential increase in the appearance of resistant strains. On the other hand, research in the field of drug-discovery has revaluated the potential of natural products as a unique source for new biologically active molecules and scaffolds for the medicinal chemistry. In this review, we first contextualized the worldwide problem of antibiotic resistance and the importance that natural products of plant origin acquire as a source of new lead compounds. We then focused on terpenes and their potential development as antimicrobials, highlighting those studies that showed an activity against conventional antibiotic-resistant strains.

11 December 2020 in Organic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
Francesca GhirgaFrancesca Ghirga
Francesca Ghirga
Deborah QuaglioDeborah Quaglio
Deborah Quaglio
MMMattia Mori
Mattia Mori
Silvia CammaroneSilvia Cammarone
Silvia Cammarone
Antonia IazzettiAntonia Iazzetti
Antonia Iazzetti
Andrea CalcaterraAndrea Calcaterra
Andrea Calcaterra
Plants represent a rich source of structurally diverse secondary metabolites, which can be exploited in the development of new clinically important compounds. Indeed, due to their biodiversity, medicinal plants represent the largest library of compounds that has ever existed. To date less than 1% of this vast biodiversity has been exploited in drug discovery, due to several factors, including the lack of an appropriate multidisciplinary perspective. Here we review the successful application of computer-aided methods in screening a unique and high-diversity in house collection library composed of around 1000 individual natural products, isolated mainly from indigenous plants collected in biodiversity-rich countries, especially of the tropics and subtropics, and enlarged with their semi-synthetic and synthetic derivatives, as well as plant material extracts, up to around 2000 components. During the last ten years, the in house library has provided several lead compounds that have been developed, and in some cases patented, as anticancer and antimicrobial agents. The main classes of the library are described, including (but not limited to) alkaloids, terpenoids, Diels–Alder-type adducts, isoflavones, chalcones, and cannabinoids. The main focus is on the chemical characteristics and biological activity of these identified compounds, with particular attention being given to those currently under patent or in the preclinical phase. We also assess the use of computer-aided methods in screening this unique and diverse in house collection of natural products that, over the last ten years, has provided some lead compounds that have been developed, and in some cases patented, as anticancer and antimicrobial agents. Finally, this review highlights the potential use of plant food extracts as a source of nutraceuticals and functional foods. The multidisciplinary approach described herein may further motivate research groups involved in natural product chemistry to potentially benefit from a limitless source of novel bioactive compounds.

14 May 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Mattia SpanoMattia Spano
Mattia Spano
Giacomo Di MatteoGiacomo Di Matteo
Giacomo Di Matteo
Cinzia IngallinaCinzia Ingallina
Cinzia Ingallina
Bruno BottaBruno Botta
Bruno Botta
Deborah QuaglioDeborah Quaglio
Deborah Quaglio
Anatoly P. SobolevAnatoly P. Sobolev
Anatoly P. Sobolev
The chemical profile of the female inflorescence extracts from seven Cannabis sativa L. dioecious cultivars (Carmagnola, Fibranova, Eletta Campana, Antal, Tiborszallasi, Kompolti, and Tisza) was monitored at three harvesting stages (4, 14, and 30 September), reaching from the beginning of flowering to end of flowering/beginning of seed formation, using untargeted nuclear magnetic resonance (NMR) and targeted (ultra-high-performance liquid chromatography (UHPLC) and spectrophotometry) analyses. The tetrahydrocannabinol content was always below the legal limits (<0.6%) in all the analyzed samples. The NMR metabolite profile (sugars, organic acids, amino acids, and minor compounds) subjected to principal components analysis (PCA) showed a strong variability according to the harvesting stages: samples harvested in stage I were characterized by a high content of sucrose and myo-inositol, whereas the ones harvested in stage II showed high levels of succinic acid, alanine, valine, isoleucine, phenylalanine, and threonine. Samples harvested in stage III were characterized by high levels of glucose, fructose, choline, trigonelline, malic acid, formic acid, and some amino acids. The ratio between chlorophylls and carotenoids content indicated that all plants grew up exposed to the sun, the Eletta Campana cultivar having the highest pigment amount. Tiborszallasi cultivar showed the highest polyphenol content. The highest antioxidant activity was generally observed in stage II. All these results suggested that the Cannabis sativa L. inflorescences of each analyzed dioecious hemp cultivar presented a peculiar chemical profile affected by the harvesting stage. This information could be useful for producers and industries to harvest inflorescences in the appropriate stage to obtain samples with a peculiar chemical profile suitable for proper applications.

4 July 2022 in Chemistry – A European Journal
Verified
Journal Article
Closed access
FSFariba Saadati
Fariba Saadati
Silvia CammaroneSilvia Cammarone
Silvia Cammarone
MCMarco A. Ciufolini
Marco A. Ciufolini

27 July 2020 in The Journal of Organic Chemistry
Verified
Journal Article
Open access
DQDeborah Quaglio
Deborah Quaglio
Maria Luisa MangoniMaria Luisa Mangoni
Maria Luisa Mangoni
RSRoberta Stefanelli
Roberta Stefanelli
SCSilvia Corradi
Silvia Corradi
Bruno CasciaroBruno Casciaro
Bruno Casciaro
Bruno BottaBruno Botta
Bruno Botta
Colistin is a last-resort antibiotic for treatment of multidrug resistant Gram-negative bacterial infections. Recently, a natural ent-beyerene diterpene was identified as a promising inhibitor of the enzyme responsible for colistin re-sistance mediated by lipid A aminoarabinosylation, in Gram-negative bacteria, namely ArnT (undecaprenyl phospha-te-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase). Here, semi-synthetic analogs of hit were designed, synthetized and tested against colistin-resistant Pseudomonas aeruginosa strains including clinical isolates, to exploit the versatility of the diterpene scaffold. Microbiological assays coupled with molecular modeling indicated that for a more efficient colistin adjuvant activity, likely resulting from inhibition of the ArnT activity by the selected com-pounds and therefore from their interaction with the catalytic site of ArnT, an ent-beyerane scaffold is required along with an oxalate like group at C-18/C-19, or a sugar residue at C-19 to resemble L-Ara4N. The ent-beyerane skeleton is identified for the first time as a privileged scaffold for further cost-effective development of valuable colistin re-sistance inhibitors.

3 October 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CPChiara Platella
Chiara Platella
Francesca GhirgaFrancesca Ghirga
Francesca Ghirga
PZPasquale Zizza
Pasquale Zizza
LPLuca Pompili
Luca Pompili
SMSimona Marzano
Simona Marzano
Daniela MontesarchioDaniela Montesarchio
Daniela Montesarchio
In the quest for selective G-quadruplex (G4)-targeting chemotypes, natural compounds have been thus far poorly explored, though representing appealing candidates due to the high structural diversity of their scaffolds. In this regard, a unique high diversity in-house library composed of ca. one thousand individual natural products was investigated. The combination of molecular docking-based virtual screening and the G4-CPG experimental screening assay proved to be useful to quickly and effectively identify—out of many natural compounds—five hit binders of telomeric and oncogenic G4s, i.e., Bulbocapnine, Chelidonine, Ibogaine, Rotenone and Vomicine. Biophysical studies unambiguously demonstrated the selective interaction of these compounds with G4s compared to duplex DNA. The rationale behind the G4 selective recognition was suggested by molecular dynamics simulations. Indeed, the selected ligands proved to specifically interact with G4 structures due to peculiar interaction patterns, while they were unable to firmly bind to a DNA duplex. From biological assays, Chelidonine and Rotenone emerged as the most active compounds of the series against cancer cells, also showing good selectivity over normal cells. Notably, the anticancer activity correlated well with the ability of the two compounds to target telomeric G4s.